| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $18.7M | — | — |
| R&D Expense | $38.2M | — | +31.1% |
| SG&A Expense | $22.3M | — | +48.4% |
| Operating Income | -$44.9M | — | -1.6% |
| Interest Expense | $382K | — | +99.0% |
| Income Tax | $0 | — | — |
| Net Income | -$36.6M | — | +29.8% |
| EPS (Basic) | -$0.37 | — | +61.5% |
| EPS (Diluted) | -$0.46 | — | +52.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $165.6M | -19.2% | +40.8% |
| Short-term Investments | $16.1M | — | — |
| Inventory | $2.3M | +24.8% | — |
| Current Assets | $202.9M | -9.2% | +62.7% |
| Total Assets | $227.8M | -7.6% | +73.0% |
| Current Liabilities | $66.8M | -7.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$52.1M | — | -34.8% |
| Investing Cash Flow | -$16.0M | — | — |
| Financing Cash Flow | $28.7M | — | -57.4% |
| +87.7% |
| Total Liabilities | $146.0M | -22.8% | -11.0% |
| Stockholders' Equity | $81.8M | +43.0% | +352.1% |